Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

被引：0
|
作者：
A A N Giagounidis
A Kulasekararaj
U Germing
R Radkowski
S Haase
P Petersen
G Göhring
G Büsche
C Aul
G J Mufti
U Platzbecker
机构：
[1] Katholisches Klinikum Duisburg,
[2] St Johannes Hospital,undefined
[3] King's College Hospital,undefined
[4] Heinrich-Heine-Universität,undefined
[5] Medizinische Hochschule Hannover,undefined
[6] Technische Universität Dresden,undefined
[7] Universitätsklinikum Carl Gustav Carus,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：855 / 858
页数：3
相关论文
共 50 条
  • [41] LENALIDOMIDE (LEN) IN MYELODYSPLASTIC (MDS) DEL(5Q) PATIENTS: A SINGLE INSTITUTION POPULATION-BASED EXPERIENCE
    Pelizzari, A.
    Cerqui, E.
    Schieppati, F.
    Borlenghi, E.
    Pagani, C.
    Bellotti, D.
    Rossi, G.
    HAEMATOLOGICA, 2013, 98 : 580 - 580
  • [42] Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
    Gurnari, Carmelo
    Piciocchi, Alfonso
    Soddu, Stefano
    Bonanni, Fabrizio
    Scalzulli, Emilia
    Niscola, Pasquale
    Di Veroli, Ambra
    Piccioni, Anna Lina
    Piedimonte, Monica
    Maiorana, Gianluca
    Salutari, Prassede
    Cicconi, Laura
    Santopietro, Michelina
    Gumenyuk, Svitlana
    Sarlo, Chiara
    Fenu, Susanna
    Tafuri, Agostino
    Latagliata, Roberto
    Fianchi, Luana
    Criscuolo, Marianna
    Maciejewski, Jaroslaw P.
    Maurillo, Luca
    Buccisano, Francesco
    Breccia, Massimo
    Voso, Maria Teresa
    BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [43] Analysis Of Transfusion Dependence Development and Disease Evolution In Patients With MDS and Del(5q) and Without Transfusion Needs At Diagnosis
    Rojas, Silvia M.
    Diez-Campelo, Maria
    Luno, Elisa
    Bernal, Teresa
    Cabrero, Monica
    Pedro, Carme
    Calabuig, Marisa
    Nomdedeu, Benet
    Cedena, Teresa
    Arrizabalaga, Beatriz
    Garcia, Marta
    Cervero, Carlos
    Collado, Rosa
    Azaceta, Gemma
    Ardanaz, MarAa Teresa
    Munoz, Juan A.
    Xicoy, Blanca
    Requena, Maria Jose
    Bargay, Joan
    Arilla, Maria Jesus
    Amigo, Luz
    Merchan, Brayan
    Simiele, Adriana
    Brunet, Salut
    Gonzalez, Bernardo
    Ramos, Fernando
    Sole, Francesc
    Consuelo, Del CaA'izo
    BLOOD, 2013, 122 (21)
  • [44] Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
    Carmelo Gurnari
    Alfonso Piciocchi
    Stefano Soddu
    Fabrizio Bonanni
    Emilia Scalzulli
    Pasquale Niscola
    Ambra Di Veroli
    Anna Lina Piccioni
    Monica Piedimonte
    Gianluca Maiorana
    Prassede Salutari
    Laura Cicconi
    Michelina Santopietro
    Svitlana Gumenyuk
    Chiara Sarlo
    Susanna Fenu
    Agostino Tafuri
    Roberto Latagliata
    Luana Fianchi
    Marianna Criscuolo
    Jaroslaw P. Maciejewski
    Luca Maurillo
    Francesco Buccisano
    Massimo Breccia
    Maria Teresa Voso
    Blood Cancer Journal, 12
  • [45] Lenalidomide Induces Ubiquitination and Degradation of CSNK1A1 in MDS with Del(5q)
    Fink, Emma C.
    Kroenke, Jan
    Hurst, Slater N.
    Udeshi, Namrata D.
    Svinkina, Tanya
    Schneider, Rebekka K.
    McConkey, Marie E.
    Jaeras, Marcus
    Bullinger, Lars
    Carr, Steven A.
    Ebert, Benjamin L.
    BLOOD, 2014, 124 (21)
  • [46] Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide
    S Park
    D Vassilieff
    V Bardet
    F Viguié
    F Dreyfus
    Leukemia, 2010, 24 : 1960 - 1962
  • [47] Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients
    Martinez-Hoyer, Sergio
    Docking, Rod
    Chan, Simon
    Jadersten, Martin
    Parker, Jeremy
    Karsan, Aly
    BLOOD, 2015, 126 (23)
  • [48] Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide
    Park, S.
    Vassilieff, D.
    Bardet, V.
    Viguie, F.
    Dreyfus, F.
    LEUKEMIA, 2010, 24 (11) : 1960 - 1962
  • [49] The role of lenalidomide in the management of myelodysplasia with del 5q
    Kelaidi, Charikleia
    Eclache, Virginie
    Fenaux, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (03) : 267 - 278
  • [50] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
12345